Literature DB >> 24453001

Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions.

Lawrence N Kwong1, Lynda Chin.   

Abstract

Although many DNA aberrations in melanoma have been well characterized, including focal amplification and deletions of oncogenes and tumor suppressors, broad regions of chromosomal gain and loss are less well understood. One possibility is that these broad events are a consequence of collateral damage from targeting single loci. Another possibility is that the loss of large regions permits the simultaneous repression of multiple tumor suppressors by broadly decreasing the resident gene dosage and expression. Here, we test this hypothesis in a targeted fashion using RNA interference to suppress multiple candidate residents in broad regions of loss. We find that loss of chromosome regions 6q, 10, and 11q21-ter is correlated with broadly decreased expression of most resident genes and that multiple resident genes impacted by broad regional loss of chromosome 10 are tumor suppressors capable of affecting tumor growth and/or invasion. We also provide additional functional support for Ablim1 as a novel tumor suppressor. Our results support the hypothesis that multiple cancer genes are targeted by regional chromosome copy number aberrations. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24453001      PMCID: PMC3971520          DOI: 10.1158/0008-5472.CAN-13-1446

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Authors:  Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
Journal:  BMC Med Genomics       Date:  2008-04-28       Impact factor: 3.063

2.  Molecular cloning, genomic structure and interactions of the putative breast tumor suppressor TACC2.

Authors:  Brenda Lauffart; Omkaram Gangisetty; Ivan H Still
Journal:  Genomics       Date:  2003-02       Impact factor: 5.736

3.  Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

Authors:  P Guldberg; P thor Straten; A Birck; V Ahrenkiel; A F Kirkin; J Zeuthen
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

4.  Genetics and genomics of melanoma.

Authors:  Papia Ghosh; Lynda Chin
Journal:  Expert Rev Dermatol       Date:  2009-04-01

5.  Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.

Authors:  C Nogueira; K-H Kim; H Sung; K H T Paraiso; J-H Dannenberg; M Bosenberg; L Chin; M Kim
Journal:  Oncogene       Date:  2010-08-16       Impact factor: 9.867

6.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Authors:  Laura Vízkeleti; Szilvia Ecsedi; Zsuzsa Rákosy; Adrienn Orosz; Viktória Lázár; Gabriella Emri; Viktória Koroknai; Tímea Kiss; Róza Ádány; Margit Balázs
Journal:  Tumour Biol       Date:  2012-09-23

8.  Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma.

Authors:  Lawrence N Kwong; James C Costello; Huiyun Liu; Shan Jiang; Timothy L Helms; Aliete E Langsdorf; David Jakubosky; Giannicola Genovese; Florian L Muller; Joseph H Jeong; Ryan P Bender; Gerald C Chu; Keith T Flaherty; Jennifer A Wargo; James J Collins; Lynda Chin
Journal:  Nat Med       Date:  2012-09-16       Impact factor: 53.440

9.  Passenger deletions generate therapeutic vulnerabilities in cancer.

Authors:  Florian L Muller; Simona Colla; Elisa Aquilanti; Veronica E Manzo; Giannicola Genovese; Jaclyn Lee; Daniel Eisenson; Rujuta Narurkar; Pingna Deng; Luigi Nezi; Michelle A Lee; Baoli Hu; Jian Hu; Ergun Sahin; Derrick Ong; Eliot Fletcher-Sananikone; Dennis Ho; Lawrence Kwong; Cameron Brennan; Y Alan Wang; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

10.  Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.

Authors:  Anthony G Uren; Jaap Kool; Konstantin Matentzoglu; Jeroen de Ridder; Jenny Mattison; Miranda van Uitert; Wendy Lagcher; Daoud Sie; Ellen Tanger; Tony Cox; Marcel Reinders; Tim J Hubbard; Jane Rogers; Jos Jonkers; Lodewyk Wessels; David J Adams; Maarten van Lohuizen; Anton Berns
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

View more
  7 in total

1.  Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.

Authors:  Whijae Roh; Pei-Ling Chen; Alexandre Reuben; Christine N Spencer; Peter A Prieto; John P Miller; Vancheswaran Gopalakrishnan; Feng Wang; Zachary A Cooper; Sangeetha M Reddy; Curtis Gumbs; Latasha Little; Qing Chang; Wei-Shen Chen; Khalida Wani; Mariana Petaccia De Macedo; Eveline Chen; Jacob L Austin-Breneman; Hong Jiang; Jason Roszik; Michael T Tetzlaff; Michael A Davies; Jeffrey E Gershenwald; Hussein Tawbi; Alexander J Lazar; Patrick Hwu; Wen-Jen Hwu; Adi Diab; Isabella C Glitza; Sapna P Patel; Scott E Woodman; Rodabe N Amaria; Victor G Prieto; Jianhua Hu; Padmanee Sharma; James P Allison; Lynda Chin; Jianhua Zhang; Jennifer A Wargo; P Andrew Futreal
Journal:  Sci Transl Med       Date:  2017-03-01       Impact factor: 17.956

2.  Signatures of Discriminative Copy Number Aberrations in 31 Cancer Subtypes.

Authors:  Bo Gao; Michael Baudis
Journal:  Front Genet       Date:  2021-05-13       Impact factor: 4.599

3.  Chromosomal and Genetic Analysis of a Human Lung Adenocarcinoma Cell Line OM.

Authors:  Yong-Wu Li; Lin Bai; Lyu-Xia Dai; Xu He; Xian-Ping Zhou
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

4.  Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.

Authors:  Jason Roszik; Chang-Jiun Wu; Alan E Siroy; Alexander J Lazar; Michael A Davies; Scott E Woodman; Lawrence N Kwong
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

5.  Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.

Authors:  Nihal Kenawy; Helen Kalirai; Joseph J Sacco; Sarah L Lake; Steffen Heegaard; Ann-Cathrine Larsen; Paul T Finger; Tatyana Milman; Kimberly Chin; Carlo Mosci; Francesco Lanza; Alexandre Moulin; Caroline A Schmitt; Jean Pierre Caujolle; Célia Maschi; Marina Marinkovic; Azzam F Taktak; Heinrich Heimann; Bertil E Damato; Sarah E Coupland
Journal:  Pigment Cell Melanoma Res       Date:  2019-02-19       Impact factor: 4.693

6.  LncRNA ZNF667-AS1 Promotes ABLIM1 Expression by Adsorbing micro RNA-1290 to Suppress Nasopharyngeal Carcinoma Cell Progression.

Authors:  Xi Chen; Yaping Huang; Dianyu Shi; Chuan Nie; Yiping Luo; Liangfen Guo; Yu Zou; Chun Xie
Journal:  Onco Targets Ther       Date:  2020-05-20       Impact factor: 4.147

7.  Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.

Authors:  Jonathan J Lee; Lynette M Sholl; Neal I Lindeman; Scott R Granter; Alvaro C Laga; Priyanka Shivdasani; Gary Chin; Jason J Luke; Patrick A Ott; F Stephen Hodi; Martin C Mihm; Jennifer Y Lin; Andrew E Werchniak; Harley A Haynes; Nancy Bailey; Robert Liu; George F Murphy; Christine G Lian
Journal:  Clin Epigenetics       Date:  2015-06-09       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.